Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Personalized cancer vaccines based on neoantigens have reached the clinical trial stage in melanoma. Different vaccination protocols showed efficacy in preclinical models without a clear indication of the quality and the number of neoantigens required for an effective cancer vaccine.
In an effort to develop potent and efficacious neoantigen-base...
Alternative Titles
Full title
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2d2cec89e01e4ec9871150c20f7cdb51
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d2cec89e01e4ec9871150c20f7cdb51
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-019-1084-4
